Respiration driven excessive sinus tachycardia treated with clonidine.
Matthew Emile LiKamWaPatricia TaraborrelliSajad HayatPhang Boon LimPublished in: BMJ case reports (2017)
A 26-year-old man presented to our syncope service with debilitating daily palpitations, shortness of breath, presyncope and syncope following a severe viral respiratory illness 4 years previously. Mobitz type II block had previously been identified, leading to a permanent pacemaker and no further episodes of frank syncope. Transthoracic echocardiography, electophysiological study and repeated urine metanepherines were normal. His palpitations and presyncope were reproducible on deep inspiration, coughing, isometric hand exercise and passive leg raises. We demonstrated rapid increases in heart rate with no change in morphology on his 12 lead ECG. His symptoms were resistant to fludrocortisone, flecainide, β blockers and ivabradine. Initiation of clonidine in combination with ivabradine led to rapid resolution of his symptoms. We suggest that an excessive respiratory sinus arrhythmia was responsible for his symptoms and achieved an excellent response with the centrally acting sympatholytic clonidine, where previous peripherally acting treatments had failed.
Keyphrases
- heart rate
- heart rate variability
- pulmonary embolism
- blood pressure
- physical activity
- sleep quality
- weight gain
- mental health
- sars cov
- computed tomography
- left ventricular
- loop mediated isothermal amplification
- pulmonary hypertension
- heart failure
- catheter ablation
- respiratory tract
- angiotensin converting enzyme
- single molecule
- newly diagnosed
- weight loss
- angiotensin ii
- quantum dots